Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HIF1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HIF1A is a gene implicated in neurodegeneration research. Key relationships include: interacts with, therapeutic target, activates. Associated with AD, ALI, ALS. Connected to 477 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | HIF |
| Full Name | 1α Protein |
| GeneCards | HIF |
| Human Protein Atlas | HIF |
| Associated Diseases | AD, ALI, Als, Alzheimer, AMI |
| Known Drugs/Compounds | quercetin, rapamycin |
| Interactions | ABCD3, AGING, AKK, AKT, AKT1, ALS |
| KG Connections | 1341 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
HIF1A(["HIF1A"])
Metabolic_Reprogramming("Metabolic Reprogramming")
IDH2["IDH2"]
Microglial_Metabolic_Reprogramming("Microglial Metabolic Reprogramming")
AEROBIC_GLYCOLYSIS["AEROBIC GLYCOLYSIS"]
GLYCOLYSIS["GLYCOLYSIS"]
Aerobic_Glycolysis["Aerobic Glycolysis"]
BMAL1["BMAL1"]
Bladder_Tumorigenesis("Bladder Tumorigenesis")
Cancer_Stemness("Cancer Stemness")
HYPOXIA["HYPOXIA"]
STRESS_GRANULE_FORMATION["STRESS GRANULE FORMATION"]
AKT1(["AKT1"])
VEGF(["VEGF"])
BNIP3(["BNIP3"])
HIF1A -->|"associated with"| Metabolic_Reprogramming
IDH2 -->|"associated with"| HIF1A
HIF1A -->|"associated with"| Microglial_Metabolic_Reprogramming
HIF1A -->|"activates"| AEROBIC_GLYCOLYSIS
HIF1A -->|"upregulates"| GLYCOLYSIS
HIF1A -->|"regulates"| Aerobic_Glycolysis
BMAL1 -->|"regulates"| HIF1A
BMAL1 -->|"interacts with"| HIF1A
HIF1A -->|"involved in"| Bladder_Tumorigenesis
HIF1A -->|"associated with"| Cancer_Stemness
HIF1A -->|"mediates"| HYPOXIA
HIF1A -->|"regulates"| STRESS_GRANULE_FORMATION
AKT1 -->|"regulates"| HIF1A
HIF1A -->|"regulates"| VEGF
HIF1A -->|"activates"| BNIP3
style HIF1A fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| HIF1A | encodes | protein | 0.00 |
| Metabolic Reprogramming | associated_with | process | 0.95 |
| Oxidative Stress | upregulates | process | 0.95 |
| cancer stemness | promotes | phenotype | 0.93 |
| lenvatinib resistance | drives | phenotype | 0.91 |
| HIF1 target genes | regulates | gene | 0.90 |
| ERRΑ | inhibits | protein | 0.90 |
| Microglial Metabolic Reprogramming | associated_with | process | 0.90 |
| NEURODEGENERATION | involved_in | disease | 0.90 |
| Metabolic Reprogramming | mediates | process | 0.90 |
| GLYCOLYSIS | upregulates | pathway | 0.90 |
| angiogenesis | promotes | process | 0.90 |
| SLC2A1 | upregulates | gene | 0.90 |
| Aerobic Glycolysis | upregulates | pathway | 0.90 |
| Aerobic Glycolysis | regulates | pathway | 0.90 |
| VEGFA | upregulates | gene | 0.90 |
| AEROBIC GLYCOLYSIS | activates | entity | 0.90 |
| Proinflammatory Macrophage Activation | promotes | process | 0.90 |
| aerobic glycolysis | associated_with | process | 0.90 |
| VEGF | upregulates | gene | 0.90 |
| PFKFB3 | upregulates | gene | 0.88 |
| HK2 | upregulates | gene | 0.88 |
| HYPOXIA | mediates | entity | 0.85 |
| Photoreceptor Cells | causes | cell_type | 0.85 |
| STRESS GRANULE FORMATION | regulates | entity | 0.85 |
| Cancer Stemness | associated_with | phenotype | 0.85 |
| ATHEROSCLEROSIS | associated_with | disease | 0.85 |
| PARKINSON'S DISEASE | involved_in | disease | 0.85 |
| ALZHEIMER'S DISEASE | involved_in | disease | 0.85 |
| Oxidative Stress | regulates | process | 0.85 |
| Angiogenesis | promotes | process | 0.85 |
| Glycolysis | upregulates | pathway | 0.85 |
| Bladder Tumorigenesis | involved_in | process | 0.85 |
| Bladder Cancer | associated_with | disease | 0.80 |
| Macrophage | expressed_in | cell_type | 0.80 |
| BDNF | regulates | protein | 0.80 |
| MITOCHONDRIA | regulates | cell_type | 0.80 |
| VEGF | regulates | gene | 0.80 |
| BNIP3 | activates | protein | 0.80 |
| Neuroprotection | promotes | process | 0.80 |
| MTOR | interacts_with | gene | 0.80 |
| DJ1 | interacts_with | gene | 0.80 |
| ferroptosis | regulates | process | 0.78 |
| Inflammation | associated_with | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Fibrosis | therapeutic_target | disease | 0.75 |
| Cardiovascular | therapeutic_target | disease | 0.75 |
| Aging | therapeutic_target | disease | 0.75 |
| NLRP3 | expresses | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HIF1A | encodes | gene | 0.00 |
| IDH2 | associated_with | entity | 0.95 |
| USP22 | deubiquitinates | protein | 0.95 |
| Autophagy | degrades | process | 0.95 |
| VHL | degrades | gene | 0.93 |
| Wnt Signaling | activates | pathway | 0.90 |
| SIRT3 | inhibits | gene | 0.90 |
| h-646ae8f1 | targets | hypothesis | 0.90 |
| UBIQUITIN | modulates | protein | 0.90 |
| hypoxia | associated_with | gene | 0.90 |
| BMAL1 | interacts_with | entity | 0.90 |
| ERRΑ | stabilizes | protein | 0.90 |
| BMAL1 | regulates | gene | 0.90 |
| JAK1/STAT1/3 | activates | pathway | 0.90 |
| Pi3K/Akt Pathway | regulates | pathway | 0.85 |
| APOE4 Microglia | upregulates | cell_type | 0.85 |
| cardamom nanoemulsion | downregulates | compound | 0.85 |
| AKT1 | regulates | protein | 0.85 |
| PI3K/AKT | regulates | pathway | 0.85 |
| PI3K/Akt | activates | pathway | 0.85 |
| HV1 | upregulates | gene | 0.85 |
| HVCN1 | upregulates | gene | 0.85 |
| PIK3CA | activates | gene | 0.82 |
| AKT1 | activates | gene | 0.82 |
| PDI | activates | protein | 0.80 |
| EGLN2 | inhibits | gene | 0.80 |
| NLRP3 inhibition | contributes_to | phenotype | 0.80 |
| FOXO3 | interacts_with | protein | 0.75 |
| GASDERMIN | activates | gene | 0.70 |
| GPX4 | activates | gene | 0.70 |
| ACHE | activates | gene | 0.70 |
| DBH | activates | gene | 0.70 |
| APOE | expresses | gene | 0.70 |
| CAT | targets | gene | 0.70 |
| BAX | activates | gene | 0.70 |
| nAChR-α7 | associated_with | gene | 0.70 |
| NF-κB | activates | gene | 0.70 |
| acetylcholine | activates | gene | 0.70 |
| TNF | associated_with | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| acetylcholine | enhances | gene | 0.70 |
| IL6 | activates | gene | 0.70 |
| nAChR-alpha7 | activates | gene | 0.70 |
| BAX | inhibits | gene | 0.70 |
| BCL2 | inhibits | gene | 0.70 |
| FRONTOTEMPORAL DEMENTIA | causes | disease | 0.65 |
| ATP | activates | gene | 0.65 |
| AMYLOID | interacts_with | protein | 0.65 |
| sorafenib | regulates | drug | 0.64 |
| STAT1 | activates | protein | 0.64 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| HIF1A stabilization lowers the activation threshold of circa | 0.566 | neuroinflammation | Do microglia actually switch between gly |
| Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α | 0.470 | neurodegeneration | What are the optimal oxygen pressure, du |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 14 hypotheses Top: 0.651
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Chromatin accessibility profiling (ATAC-seq) revealed unique chromatin | computational | Parkinson's disease | 0.500 | 0.00 | postmortem_human_tissue | extracted | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.86 · 2026-04-12
closed · Rounds: 5 · Score: 0.95 · 2026-04-12
Hypotheses and analyses mentioning HIF1A in their description or question text
No additional research found